The shift towards more home-based and distance-care may further change in a post-COVID environment.
Healthcare systems around the world are under increasing pressure to treat a rapidly growing, aging population. This was worsened by the COVID-19 pandemic, which left medical professionals needing to treat more people with less time and limited resources. This article explores why medtech is uniquely placed to ease the pressures on healthcare systems by offering faster and more cost-effective care while improving patient outcomes.
The program highlights the agency’s commitment to improving safety and supporting innovation, and is a welcome counterpart to the Breakthrough Devices Program.
We have the opportunity to refine processes that were implemented in a hurry during the pandemic, along with the insight to improve the entire healthcare system.
The record-high number of authorizations last year was a significant jump over 2019.
Among the many lessons from the COVID-19 pandemic, it’s clear that the future of healthcare belongs to those who can harness science and technology—sometimes rapidly—to improve population health through more efficient and accessible care.
Quantum computing has spurred the development of new breakthroughs in life sciences from using machine learning methods to diagnose illnesses sooner to identifying materials to make more efficient devices.
No longer just “the big company advantage,” CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.
No longer just “the big company advantage,” Arlen Ward discusses how CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.
The center intends to facilitate partnerships, exchange knowledge and promote innovative regulatory approaches.